Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 164,188 shares at $70.56 ($11.8M) on 2022-04-04, disclosed to the SEC on 2022-04-05.
Open-market sale of $11.8M ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.75 | 8,299 | $587K | 5.0% |
| 2 | $70.75 | 8,299 | $587K | 5.0% |
| 3 | $71.32 | 42,260 | $3.0M | 25.6% |
| 4 | $71.32 | 42,260 | $3.0M | 25.6% |
| 5 | $70.56 | 2,500 | $176K | 1.5% |
| 6 | $71.71 | 18,076 |
| $1.3M |
| 11.0% |
| 7 | $71.71 | 18,076 | $1.3M | 11.0% |
| 8 | $72.65 | 3,200 | $232K | 2.0% |
| 9 | $72.65 | 3,200 | $232K | 2.0% |
| 10 | $73.42 | 9,009 | $661K | 5.6% |
| 11 | $73.42 | 9,009 | $661K | 5.6% |
| Total | $71.62 avg | 164,188 | $11.8M | 100% |
| Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |
| ENTA | SELL | 2021-10-13 | $2.5M | — | Filing → |